SPKAR SPK Acquisition Corp - Right

SPK Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on operating businesses in the telecommunications, media, and technology sectors in Asia. The company was incorporated in 2020 and is based in Shanghai, China.  This security was issued by SPK Acquisition Corp, whose common stock symbol is SPK.

On 2/14/2022 the company announced a proposed merger with Varian Biopharmaceuticals, Inc. (“Varian Bio”), a private, precision oncology company developing novel therapeutics for the treatment of cancer.  

As of 04/21/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Rights
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  07/23/2021
Outstanding shares:  301,929,497
Average volume:  60,000
Market cap:   $66,424,489
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy